title: Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.
abstract: In the present study, it was shown that physiologically relevant levels of the proinflammatory cytokine TNFalpha induced apoptosis in rat cardiomyocytes in vitro, as quantified by single cell microgel electrophoresis of nuclei ("cardiac comets") as well as by morphological and biochemical criteria. It was also shown that TNFalpha stimulated production of the endogenous second messenger, sphingosine, suggesting sphingolipid involvement in TNFalpha-mediated cardiomyocyte apoptosis. Consistent with this hypothesis, sphingosine strongly induced cardiomyocyte apoptosis. The ability of the appropriate stimulus to drive cardiomyocytes into apoptosis indicated that these cells were primed for apoptosis and were susceptible to clinically relevant apoptotic triggers, such as TNFalpha. These findings suggest that the elevated TNFalpha levels seen in a variety of clinical conditions, including sepsis and ischemic myocardial disorders, may contribute to TNFalpha-induced cardiac cell death. Cardiomyocyte apoptosis is also discussed in terms of its potential beneficial role in limiting the area of cardiac cell involvement as a consequence of myocardial infarction, viral infection, and primary cardiac tumors.
authors.affiliation: Department of Biology, San Diego State University, California 92182, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Krown
authors.forename: M T
authors.initials: MT
authors.lastname: Page
authors.forename: C
authors.initials: C
authors.lastname: Nguyen
authors.forename: D
authors.initials: D
authors.lastname: Zechner
authors.forename: V
authors.initials: V
authors.lastname: Gutierrez
authors.forename: K L
authors.initials: KL
authors.lastname: Comstock
authors.forename: C C
authors.initials: CC
authors.lastname: Glembotski
authors.forename: P J
authors.initials: PJ
authors.lastname: Quintana
authors.forename: R A
authors.initials: RA
authors.lastname: Sabbadini
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D001583:Benzoxazoles / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D002518:Ceramides / Q000494:pharmacology; D004249:DNA Damage / Q000235:genetics; D004587:Electrophoresis, Agar Gel; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007091:Image Processing, Computer-Assisted; D008856:Microscopy, Fluorescence; D017202:Myocardial Ischemia / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D011806:Quinolinium Compounds / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction / Q000502:physiology; D013107:Sphingolipids / Q000378:metabolism / Q000494:pharmacology; D013110:Sphingosine / Q000378:metabolism / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D001583:Benzoxazoles; D002518:Ceramides; D011806:Quinolinium Compounds; D013107:Sphingolipids; D014409:Tumor Necrosis Factor-alpha; C075296:1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinolinium; D006861:Hydrogen Peroxide; D013110:Sphingosine